Giuseppa Ferraro

570 total citations
19 papers, 421 citations indexed

About

Giuseppa Ferraro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Giuseppa Ferraro has authored 19 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Giuseppa Ferraro's work include HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (5 papers). Giuseppa Ferraro is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (5 papers). Giuseppa Ferraro collaborates with scholars based in Italy, United States and Spain. Giuseppa Ferraro's co-authors include Vincenzo Adamo, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, Alessandro Russo, Mariangela Zanghì, Antonio Picone, Antonio Giordano, Giuseppe Toscano, Bárbara Adamo and Antonino Scimone and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Giuseppa Ferraro

19 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppa Ferraro Italy 10 261 205 132 101 54 19 421
K. L. Blackwell United States 7 311 1.2× 103 0.5× 118 0.9× 71 0.7× 93 1.7× 16 438
Takuro Yukawa Japan 13 366 1.4× 202 1.0× 115 0.9× 98 1.0× 57 1.1× 37 614
Mariangela Zanghì Italy 7 234 0.9× 211 1.0× 144 1.1× 79 0.8× 40 0.7× 12 414
Feiyu Niu China 12 266 1.0× 314 1.5× 175 1.3× 130 1.3× 23 0.4× 25 513
Peijian Peng China 14 558 2.1× 385 1.9× 183 1.4× 152 1.5× 34 0.6× 26 834
Jiajia Gu China 13 131 0.5× 123 0.6× 296 2.2× 188 1.9× 17 0.3× 20 435
Bhumsuk Keam South Korea 9 312 1.2× 134 0.7× 98 0.7× 56 0.6× 46 0.9× 17 568
Muhammad Alamgeer Australia 13 346 1.3× 184 0.9× 294 2.2× 176 1.7× 20 0.4× 25 615
James D. Peyton United States 10 200 0.8× 145 0.7× 175 1.3× 53 0.5× 10 0.2× 27 363

Countries citing papers authored by Giuseppa Ferraro

Since Specialization
Citations

This map shows the geographic impact of Giuseppa Ferraro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppa Ferraro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppa Ferraro more than expected).

Fields of papers citing papers by Giuseppa Ferraro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppa Ferraro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppa Ferraro. The network helps show where Giuseppa Ferraro may publish in the future.

Co-authorship network of co-authors of Giuseppa Ferraro

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppa Ferraro. A scholar is included among the top collaborators of Giuseppa Ferraro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppa Ferraro. Giuseppa Ferraro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Adamo, Vincenzo, et al.. (2016). Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer. OncoTargets and Therapy. Volume 9. 4351–4355. 3 indexed citations
2.
Russo, Alessandro, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, et al.. (2016). Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance. Expert Review of Anticancer Therapy. 16(6). 615–623. 19 indexed citations
3.
Ricciardi, Giuseppina Rosaria Rita, et al.. (2015). Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases. OncoTargets and Therapy. 8. 289–289. 12 indexed citations
4.
Ricciardi, Giuseppina Rosaria Rita, Bárbara Adamo, Antonio Ieni, et al.. (2015). Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. PLoS ONE. 10(6). e0128368–e0128368. 55 indexed citations
5.
Russo, Alessandro, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, et al.. (2015). A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives. Oncotarget. 6(29). 26814–26825. 137 indexed citations
6.
Ricciardi, Giuseppina Rosaria Rita, Alessandro Russo, Tindara Franchina, et al.. (2014). NSCLC and HER2: Between Lights and Shadows. Journal of Thoracic Oncology. 9(12). 1750–1762. 54 indexed citations
7.
Ricciardi, Giuseppina Rosaria Rita, Claudia Proto, Giuseppa Ferraro, & Vincenzo Adamo. (2014). Uncommon Breast Metastatic Site and Eribulin Responsiveness in a Heavily Pretreated Patient. Future Oncology. 10(15). 2417–2422. 3 indexed citations
8.
Adamo, Vincenzo, Giuseppina Rosaria Rita Ricciardi, Bárbara Adamo, et al.. (2013). The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population. Oncology. 86(1). 16–21. 21 indexed citations
9.
Adamo, Vincenzo, Giuseppina Rosaria Rita Ricciardi, Bárbara Adamo, et al.. (2012). Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series.. Journal of Clinical Oncology. 30(15_suppl). e11056–e11056. 1 indexed citations
10.
Adamo, Vincenzo, Vito Lorusso, Rosalba Rossello, et al.. (2008). Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study. British Journal of Cancer. 98(12). 1916–1921. 20 indexed citations
11.
Adamo, Vincenzo, et al.. (2008). Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients. Expert Opinion on Pharmacotherapy. 9(8). 1351–1361. 15 indexed citations
12.
Franchina, Tindara, Bárbara Adamo, Eleonora Restuccia, et al.. (2008). Role of MTHFR polymorphisms as predictive markers of acute toxicity during 5-fluorouracil based chemotherapy for colorectal cancer: Preliminary data. Journal of Clinical Oncology. 26(15_suppl). 15036–15036. 3 indexed citations
13.
Adamo, Vincenzo, Tindara Franchina, Bárbara Adamo, et al.. (2007). Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study). Annals of Oncology. 18. vi11–vi15. 21 indexed citations
14.
Ferraro, Giuseppa, et al.. (2006). Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care.. PubMed. 14(1). E1–E1. 1 indexed citations
15.
Adamo, Vincenzo, Giuseppa Ferraro, Stefano Pergolizzi, et al.. (2004). Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma. Oral Oncology. 40(5). 525–531. 37 indexed citations
16.
Pergolizzi, Stefano, Giuseppa Ferraro, Anna Santacaterina, et al.. (2004). Induction Chemotherapy to Weekly Paclitaxel Concurrent with Curative Radiotherapy in Stage IV (M0) Unresectable Head and Neck Squamous Cell Carcinoma: a Dose Escalation Study. Journal of Chemotherapy. 16(2). 201–205. 4 indexed citations
17.
Scimone, Antonino, R. Maisano, Giuseppe Altavilla, et al.. (1999). Etoposide,l-Leucovorin and Fluorouracil (ELF) Regimen in Metastatic Gastric Cancer: A Phase II Study. Journal of Chemotherapy. 11(1). 74–77. 6 indexed citations
18.
Maisano, R., Giuseppe Altavilla, Armando D’Angelo, et al.. (1999). Phase II study paclitaxel (PTX) and cisplatin (Cis) in advanced and recurrent head&neck cancer. European Journal of Cancer. 35. S178–S178. 4 indexed citations
19.
Bartoloni, Giovanni, et al.. (1997). Histopathology of Thalassemic Heart Disease: An Endomyocardial Biopsy Study. Cardiovascular Pathology. 6(4). 205–211. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. L. Blackwell Breakdown of academic impact, for papers by Takuro Yukawa Breakdown of academic impact, for papers by Mariangela Zanghì Breakdown of academic impact, for papers by Feiyu Niu Breakdown of academic impact, for papers by Peijian Peng Breakdown of academic impact, for papers by Jiajia Gu Breakdown of academic impact, for papers by Bhumsuk Keam Breakdown of academic impact, for papers by Muhammad Alamgeer Breakdown of academic impact, for papers by James D. Peyton
Rankless by CCL
2026